485 related articles for article (PubMed ID: 25162667)
1. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Silverberg SJ; Clarke BL; Peacock M; Bandeira F; Boutroy S; Cusano NE; Dempster D; Lewiecki EM; Liu JM; Minisola S; Rejnmark L; Silva BC; Walker MD; Bilezikian JP
J Clin Endocrinol Metab; 2014 Oct; 99(10):3580-94. PubMed ID: 25162667
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Eastell R; Brandi ML; Costa AG; D'Amour P; Shoback DM; Thakker RV
J Clin Endocrinol Metab; 2014 Oct; 99(10):3570-9. PubMed ID: 25162666
[TBL] [Abstract][Full Text] [Related]
3. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Udelsman R; Åkerström G; Biagini C; Duh QY; Miccoli P; Niederle B; Tonelli F
J Clin Endocrinol Metab; 2014 Oct; 99(10):3595-606. PubMed ID: 25162669
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.
Bilezikian JP; Brandi ML; Eastell R; Silverberg SJ; Udelsman R; Marcocci C; Potts JT
J Clin Endocrinol Metab; 2014 Oct; 99(10):3561-9. PubMed ID: 25162665
[TBL] [Abstract][Full Text] [Related]
5. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Silverberg SJ; Lewiecki EM; Mosekilde L; Peacock M; Rubin MR
J Clin Endocrinol Metab; 2009 Feb; 94(2):351-65. PubMed ID: 19193910
[TBL] [Abstract][Full Text] [Related]
6. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.
Marcocci C; Bollerslev J; Khan AA; Shoback DM
J Clin Endocrinol Metab; 2014 Oct; 99(10):3607-18. PubMed ID: 25162668
[TBL] [Abstract][Full Text] [Related]
7. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Khan A; Grey A; Shoback D
J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Eastell R; Arnold A; Brandi ML; Brown EM; D'Amour P; Hanley DA; Rao DS; Rubin MR; Goltzman D; Silverberg SJ; Marx SJ; Peacock M; Mosekilde L; Bouillon R; Lewiecki EM
J Clin Endocrinol Metab; 2009 Feb; 94(2):340-50. PubMed ID: 19193909
[TBL] [Abstract][Full Text] [Related]
9. An overview of normocalcemic primary hyperparathyroidism.
Pawlowska M; Cusano NE
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
[TBL] [Abstract][Full Text] [Related]
10. Classical and Nonclassical Manifestations of Primary Hyperparathyroidism.
El-Hajj Fuleihan G; Chakhtoura M; Cipriani C; Eastell R; Karonova T; Liu JM; Minisola S; Mithal A; Moreira CA; Peacock M; Schini M; Silva B; Walker M; El Zein O; Marcocci C
J Bone Miner Res; 2022 Nov; 37(11):2330-2350. PubMed ID: 36245249
[TBL] [Abstract][Full Text] [Related]
11. MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects.
Verdelli C; Corbetta S
Eur J Endocrinol; 2017 Jan; 176(1):R39-R52. PubMed ID: 27601015
[TBL] [Abstract][Full Text] [Related]
12. [Primary hyperparathyroidism: new concepts, new recommendations].
Crouzeix G; Kerlan V
Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S21-36. PubMed ID: 25617920
[TBL] [Abstract][Full Text] [Related]
13. Normocalcemic primary hyperparathyroidism.
Cusano NE; Cetani F
Arch Endocrinol Metab; 2022 Nov; 66(5):666-677. PubMed ID: 36382756
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation and management of patients with primary hyperparathyroidism in Italy.
Saponaro F; Cetani F; Repaci A; Pagotto U; Cipriani C; Pepe J; Minisola S; Cipri C; Vescini F; Scillitani A; Salcuni A; Palmieri S; Eller-Vainicher C; Chiodini I; Madeo B; Kara E; Castellano E; Borretta G; Gianotti L; Romanelli F; Camozzi V; Faggiano A; Corbetta S; Cianferotti L; Brandi ML; De Feo ML; Palermo A; Vezzoli G; Maino F; Scalese M; Marcocci C
J Endocrinol Invest; 2018 Nov; 41(11):1339-1348. PubMed ID: 29616419
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic primary hyperparathyroidism: new issues and new questions--bridging the past with the future.
Bilezikian JP; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N57-67. PubMed ID: 12412779
[TBL] [Abstract][Full Text] [Related]
16. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Udelsman R; Pasieka JL; Sturgeon C; Young JE; Clark OH
J Clin Endocrinol Metab; 2009 Feb; 94(2):366-72. PubMed ID: 19193911
[TBL] [Abstract][Full Text] [Related]
17. Nontraditional manifestations of primary hyperparathyroidism.
Walker MD; Rubin M; Silverberg SJ
J Clin Densitom; 2013; 16(1):40-7. PubMed ID: 23374740
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic primary hyperparathyroidism.
Silverberg SJ; Walker MD; Bilezikian JP
J Clin Densitom; 2013; 16(1):14-21. PubMed ID: 23374736
[TBL] [Abstract][Full Text] [Related]
19. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.
Pallan S; Khan A
Can Fam Physician; 2011 Feb; 57(2):184-9. PubMed ID: 21321169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
